Guangzhou Baiy | 600332 - Operating Expenses


Guangzhou Baiy reported CNY18.32B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Aspen Pharmacare ZAR 13.32B 5.36B Dec/2025
Cipla INR 63.61B 1.3B Sep/2026
Dr.Reddys Laboratories INR 74.82B 2.93B Sep/2026
Jiangsu Hengrui CNY 6.01B 449.22M Sep/2026
Kalbe Farma IDR 8.36T 303.36B Mar/2026
Richter Gedeon HUF 157.88B 6.77B Mar/2026
Sh Fosun Pharma CNY 9.09B 637.86M Sep/2026
Sh Pharmaceutical CNY 69.22B 3.14B Jun/2026
Sun Pharmaceuticals INR 117.43B 648.5M Jun/2026
Teva Pharmaceutical Industries USD 3.92B 691M Jun/2026